Lexeo Therapeutics, Inc. Common Stock
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Lexeo Therapeutics, Inc. Common Stock's balance sheet done over the years? Its assets were worth $139,807,000 last year, which is more than in the previous period. 19% of Lexeo Therapeutics, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $26,272,000, which means an decrease by -87% compared compared to last year.

Debt to Assets

Lexeo Therapeutics, Inc. Common Stock (NASDAQ:LXEO): Debt to assets
2020 29409281 34.94M 118.83%
2021 136860000 192.46M 140.63%
2022 97076000 210.03M 216.36%
2023 139807000 26.27M 18.79%

LXEO Balance Sheet (2020 – 2023)

2023 2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
 121.46M77.33M135.86M29.37M
Short term investments
 0000
Net receivables
 0000
Inventory
 0000
Other current assets
 2.82M371K696K33.57K
Total current assets
 124.29M80.04M136.68M29.40M
Non-current assets:
Property, Plant and Equipment
 12.26M13.77M174K0
Goodwill
 0000
Intangible assets
 0000
Long term investments
 3.25M000
Other non-current assets
 03.25M2K2.5K
Total non-current assets
 15.51M17.02M176K2.5K
Total assets
 139.80M97.07M136.86M29.40M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
 08.59M46K140.38K
Short term debt
 5.21M2.83M4.31M513.01K
Total current liabilities
 17.23M14.34M7.44M697.72K
Non-current liabilities:
Long term debt
 9.03M10.64M00
Deferred tax
 0000
Other non-current liabilities
 0185.03M00
Total non-current liabilities
 9.03M195.68M185.01M34.24M
Total liabilities
 26.27M210.03M192.46M34.94M
Data source